SEARCH
YOUR SEARCH FOR Text 163 RESULTS
61 of Total
Compliance & Transparency | Incyte.com
… Compliance & Transparency We aim to make a difference … integrity, making information available as needed to our patients, employees, global …
Read More
62 of Total
Terms of Use | Incyte.com
… INCYTE TERMS OF USE The website www.incyte.com and related websites that link to this notice are provided by Incyte Corporation ("Incyte"). PLEASE …
Read More
63 of Total
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advance
… View all news Incyte Announces Positive CHMP Opinion … EST PDF Version Pending the European Commission decision, Zynyz ® (retifanlimab) in combination …
Read More
64 of Total
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatm
… View all news Incyte Announces the European … compared to chemotherapy alone. 1 WILMINGTON, Del. --(BUSINESS WIRE)--Mar. 6, 2026-- Incyte …
Read More
65 of Total
Incyte.com Cookie Policy
… Incyte Cookie Policy Last Updated: March 12, 2025 In operating our … this through the use of cookies placed on the device or browser you use to visit our websites. …
Read More
66 of Total
What Can JAK Inhibition Do? More Than You Might Think | Incyte.com
… November 20, 2022 What Can JAK Inhibition Do? More Than You Might … scientists have focused on exploring the wide-reaching impacts of the immune system. Our …
Read More
67 of Total
Hematology and Oncology Research | Incyte.com
… Transforming the Treatment Landscape in Hematology and Oncology For decades, we have leveraged our world-class …
Read More
68 of Total
Community-Driven Innovation with the Incyte Ingenuity Awards | Incyte Stories
… 13, 2024 Supporting Community-Driven Innovation with the Incyte Ingenuity Awards Incyte’s … extends beyond driving innovation in the lab to developing and supporting programs that can make …
Read More
69 of Total
Incyte Stories from Researchers and Scientists | Incyte.com
… Incyte in 2026 and Beyond: Focus, Momentum & Patient Impact … View Story The Unseen Journey Expands with Debut of MPN Visual AI zer View Story Progress …
Read More
70 of Total
… SCHEDULE 13G CUSIP No. 1 Names of Reporting Persons The Vanguard Group 2 … box if the aggregate amount in row (9) excludes certain shares (See Instructions) 11 Percent …
Read More